1. Park, Hak, Seo, Soo Kyung, Sim, Ju-Ri, Lee, Jae Myun, Lee, Min Goo. 2022. TMED3 Complex Mediates ER Stress-Associated Secretion of CFTR, Pendrin, and SARS-CoV-2 Spike. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 9, e2105320. doi:10.1002/advs.202105320. https://pubmed.ncbi.nlm.nih.gov/35748162/
2. Zheng, Hao, Yang, Yuan, Han, Jun, Ren, Hao, Zhou, Wei-Ping. 2016. TMED3 promotes hepatocellular carcinoma progression via IL-11/STAT3 signaling. In Scientific reports, 6, 37070. doi:10.1038/srep37070. https://pubmed.ncbi.nlm.nih.gov/27901021/
3. Zhu, Weian, Zeng, Hengda, Huang, Jiongduan, Luo, Yun, Lai, Wenjie. 2023. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer. In Journal of translational medicine, 21, 782. doi:10.1186/s12967-023-04633-2. https://pubmed.ncbi.nlm.nih.gov/37925432/
4. Yang, Yuxian, Liu, Shiliang, Xie, Chunxia, Xi, Mian, Zhao, Lei. 2022. Trafficking protein TMED3 promotes esophageal squamous cell carcinoma. In Biomedical journal, 46, 100528. doi:10.1016/j.bj.2022.03.013. https://pubmed.ncbi.nlm.nih.gov/35358714/
5. Xu, Wei, Li, Yifan, Ye, Xiaojian, Zhang, Xiangyang, Li, Zhikun. 2021. TMED3/RPS15A Axis promotes the development and progression of osteosarcoma. In Cancer cell international, 21, 630. doi:10.1186/s12935-021-02340-w. https://pubmed.ncbi.nlm.nih.gov/34838013/
6. Liao, Gang, Zhang, Meimei, Wang, Chunliang. 2022. Analysis and Validation of TMED3 correlates with poor prognosis and tumor immune infiltration of glioma. In Journal of cancer research and clinical oncology, 149, 3485-3494. doi:10.1007/s00432-022-04257-x. https://pubmed.ncbi.nlm.nih.gov/35951089/
7. Xie, An, Xu, Xinping, Kuang, Peng, Zhang, Ling, Yu, Feng. 2021. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR. In Cell death & disease, 12, 804. doi:10.1038/s41419-021-04086-9. https://pubmed.ncbi.nlm.nih.gov/34429402/
8. Yang, Jinxing, Huang, Hanwen, Xiao, Dan, Zheng, Yanfang, Chen, Zhong. 2021. Knockdown of TMED3 inhibits cell viability and migration and increases apoptosis in human chordoma cells. In International journal of oncology, 58, . doi:10.3892/ijo.2021.5195. https://pubmed.ncbi.nlm.nih.gov/33760171/
智鼠故事 
